Department of Surgery, University of Texas Health San Antonio, San Antonio, TX, USA.
Department of Population Health Sciences, University of Texas Health San Antonio, San Antonio, TX, USA.
Medicine (Baltimore). 2022 Dec 16;101(50):e32037. doi: 10.1097/MD.0000000000032037.
We analyzed differences (charges, total, and variable costs) in estimating cost savings of quality improvement projects using reduction of serious/life-threatening complications (Clavien-Dindo Level IV) and insurance type (Private, Medicare, and Medicaid/Uninsured) to evaluate the cost measures. Multiple measures are used to analyze hospital costs and compare cost outcomes across health systems with differing patient compositions. We used National Surgical Quality Improvement Program inpatient (2013-2019) with charge and cost data in a hospital serving diverse socioeconomic status patients. Simulation was used to estimate variable costs and total costs at 3 proportions of fixed costs (FC). Cases (Private 1517; Medicare 1224; Medicaid/Uninsured 3648) with patient mean age 52.3 years (Standard Deviation = 14.7) and 47.3% male. Medicare (adjusted odds ratio = 1.55, 95% confidence interval = 1.16-2.09, P = .003) and Medicaid/Uninsured (adjusted odds ratio = 1.41, 95% confidence interval = 1.10-1.82, P = .008) had higher odds of complications versus Private. Medicaid/Uninsured had higher relative charges versus Private, while Medicaid/Uninsured and Medicare had higher relative variable and total costs versus Private. Targeting a 15% reduction in serious complications for robust patients undergoing moderate-stress procedures estimated variable cost savings of $286,392. Total cost saving estimates progressively increased with increasing proportions of FC; $443,943 (35% FC), $577,495 (50% FC), and $1184,403 (75% FC). In conclusion, charges did not identify increased costs for Medicare versus Private patients. Complications were associated with > 200% change in costs. Surgical hospitalizations for Medicare and Medicaid/Uninsured patients cost more than Private patients. Variable costs should be used to avoid overestimating potential cost savings of quality improvement interventions, as total costs include fixed costs that are difficult to change in the short term.
我们分析了使用严重/危及生命并发症减少(Clavien-Dindo 分级 IV)和保险类型(私人、医疗保险和医疗补助/无保险)来估算质量改进项目成本节约的差异(费用、总费用和可变成本),以评估成本措施。使用国家手术质量改进计划住院患者(2013-2019 年)的数据,费用和成本数据来自一家为不同社会经济地位患者提供服务的医院。模拟用于估计 3 个固定成本(FC)比例下的可变成本和总成本。病例(私人 1517 例;医疗保险 1224 例;医疗补助/无保险 3648 例)患者平均年龄 52.3 岁(标准差 14.7),男性占 47.3%。医疗保险(调整后的优势比 1.55,95%置信区间 1.16-2.09,P = 0.003)和医疗补助/无保险(调整后的优势比 1.41,95%置信区间 1.10-1.82,P = 0.008)与私人保险相比,并发症的可能性更高。与私人保险相比,医疗补助/无保险的相对费用较高,而医疗补助/无保险和医疗保险的相对可变成本和总费用较高。对于接受中度压力手术的健壮患者,目标是将严重并发症减少 15%,估计可变成本节约 286392 美元。随着 FC 比例的增加,总节省成本估计值逐渐增加;35%FC 为 443943 美元,50%FC 为 577495 美元,75%FC 为 1184403 美元。总之,与私人保险患者相比,医疗保险的费用并没有增加。并发症与成本变化超过 200%有关。医疗保险和医疗补助/无保险患者的住院手术费用高于私人保险患者。可变成本应予以考虑,以避免高估质量改进干预措施的潜在成本节约,因为总费用包括短期内难以改变的固定成本。